Better Outcomes
in Early Stages of Life

WHO WE ARE

 

Babynostics is developing diagnostics and treatment solutions based on the research of Professor David Silver at Duke-NUS on MFSD2a and Lysophospatidylcholine (LPC) lipids. His key discovery was published in Nature on May 2014: ”Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid”.

 

Our Science

 

Diagnostics

 

Treatment

OUR TEAM

Dr Michael Shleifer


Contact Me

Laurent Benissan


Contact Me

Dr. Richard Gelling


Contact Me

Dr David Silver

Scientific Founder

Contact Me

PARTNERS